167 related articles for article (PubMed ID: 34093572)
1. TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction
Cheng L; Li G; Pellegry CM; Yasui F; Li F; Zurawski SM; Zurawski G; Levy Y; Ting JP; Su L
Front Immunol; 2021; 12():672143. PubMed ID: 34093572
[TBL] [Abstract][Full Text] [Related]
2. TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice.
Godot V; Tcherakian C; Gil L; Cervera-Marzal I; Li G; Cheng L; Ortonne N; Lelièvre JD; Pantaleo G; Fenwick C; Centlivre M; Mouquet H; Cardinaud S; Zurawski SM; Zurawski G; Milpied P; Su L; Lévy Y
PLoS Pathog; 2020 Nov; 16(11):e1009025. PubMed ID: 33253297
[TBL] [Abstract][Full Text] [Related]
3. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
He B; Qiao X; Cerutti A
J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
[TBL] [Abstract][Full Text] [Related]
4. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.
Chung NP; Matthews K; Klasse PJ; Sanders RW; Moore JP
J Immunol; 2012 Dec; 189(11):5257-65. PubMed ID: 23100517
[TBL] [Abstract][Full Text] [Related]
7. Slc15a4 function is required for intact class switch recombination to IgG2c in response to TLR9 stimulation.
Dosenovic P; Ádori M; Adams WC; Pedersen GK; Soldemo M; Beutler B; Karlsson Hedestam GB
Immunol Cell Biol; 2015 Feb; 93(2):136-46. PubMed ID: 25310967
[TBL] [Abstract][Full Text] [Related]
8. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM
Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345
[TBL] [Abstract][Full Text] [Related]
9. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
[TBL] [Abstract][Full Text] [Related]
10. Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system.
Cheng L; Zhang Z; Li G; Li F; Wang L; Zhang L; Zurawski SM; Zurawski G; Levy Y; Su L
Vaccine; 2017 Oct; 35(45):6143-6153. PubMed ID: 28958808
[TBL] [Abstract][Full Text] [Related]
11. IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences.
Duramad O; Fearon KL; Chan JH; Kanzler H; Marshall JD; Coffman RL; Barrat FJ
Blood; 2003 Dec; 102(13):4487-92. PubMed ID: 12946990
[TBL] [Abstract][Full Text] [Related]
12. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II.
Benitez-Ribas D; Tacken P; Punt CJ; de Vries IJ; Figdor CG
J Immunol; 2008 Oct; 181(8):5219-24. PubMed ID: 18832675
[TBL] [Abstract][Full Text] [Related]
13. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
[TBL] [Abstract][Full Text] [Related]
14. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
Carpenter EL; Mick R; Rüter J; Vonderheide RH
J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
[TBL] [Abstract][Full Text] [Related]
15. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells: the key to CpG.
Rothenfusser S; Tuma E; Endres S; Hartmann G
Hum Immunol; 2002 Dec; 63(12):1111-9. PubMed ID: 12480254
[TBL] [Abstract][Full Text] [Related]
17. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
Krug A; Rothenfusser S; Hornung V; Jahrsdörfer B; Blackwell S; Ballas ZK; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Jul; 31(7):2154-63. PubMed ID: 11449369
[TBL] [Abstract][Full Text] [Related]
18. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation.
Gujer C; Sundling C; Seder RA; Karlsson Hedestam GB; Loré K
Immunology; 2011 Nov; 134(3):257-69. PubMed ID: 21977996
[TBL] [Abstract][Full Text] [Related]
19. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]